The Ozempic manufacturer is developing a new medicine — they claim it will help you lose weight by 25%

Author:
Anastasiia Mohylevets
Date:

The pharmaceutical company Eli Lilly & Co introduced the drug Zepbound, also known as Mounjaro. It may be more effective for weight loss than Ozempic and Wegovy from the Danish corporation Novo Nordisk. However, Novo Nordisk is already testing a new medicine that can help you lose at least 25% of your weight.

This is reported by Bloomberg.

Other manufacturers also create injections and pills that are easier to take. The price of semaglutide

A drug used to treat diabetes and obesity. The substance reduces appetite and can significantly reduce body weight. This is the key active ingredient in Ozempic and Wegovy
in the US will change next year, and the European patent will expire in 2031. In China, semaglutide is legal until 2026. According to the publication, manufacturers from the PRC already want to enter the market with generics
Analogues of patented drugs, which may differ from the original in terms of composition, cost, etc.
.

In order not to lose leadership in the industry, Novo Nordisk produced the compound kagrilintide

A substance that mimics the action of amylin, a hormone secreted by the pancreas. Amylin regulates blood glucose levels and appetite.
. Semaglutide, which slows the movement of food through the digestive system by mimicking the hormone GLP-1, and cagrilintide together form the CagriSema hybrid. This method of treating excess weight can become the most effective and at the same time does not cause more side effects than the drug Wegovy.

Novo Nordiskʼs experts suggested that the combination could even prevent the so-called yo-yo effect, where people regain the weight they lost once they stop taking the drug. They are also studying whether CagriSema can treat type 2 diabetes.

  • The main task of Ozempic is to reduce the level of sugar and hemoglobin in the blood of patients with type 2 diabetes. The drug also slows down the development of chronic kidney disease and reduces the amount of fat in the liver.
  • However, Novo Nordiskʼs development gained popularity due to its effectiveness for weight loss. In March 2024, Ozempic and Wegovy began to disappear en masse from the shelves of pharmacies, despite the high price. A monthʼs supply of Wegovy costs over $1 300, while Ozempic costs about $900. They began to be used not only by people who suffered from obesity, but also by those who wanted to quickly lose a few kilograms. Novo Nordisk drugs have become scarce.
  • In June of the same year, the World Health Organization reported that in some countries, counterfeit drugs of the Danish corporation for diabetes are being distributed.

For more news and in-depth stories from Ukraine please follow us on X.